← Back to Search

Noninvasive Brain Stimulation

tDCS and fatigue for Post-COVID Syndrome

N/A

Recruiting

Research Sponsored by Thorsten Rudroff

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will investigate if multiple sessions of 4 mA M1 tDCS can improve fatigue and brain activity in recovered COVID-19 patients.

Eligible Conditions

Post-COVID Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

6-minute walk test

Fatigue Assessment Scale (FAS)

Fatigue Severity Scale (FSS)

+1 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: tDCS and fatigueActive Control1 Intervention

This group will receive the active form of tDCS.

Group II: Sham and fatiguePlacebo Group1 Intervention

This group will receive the sham form of tDCS.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thorsten RudroffLead Sponsor

4 Previous Clinical Trials

80 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial currently enrolling participants?

"Affirmative. According to records on clinicaltrials.gov, this medical study is actively enrolling patients and has been since June 15th 2022. The research requires 50 volunteers from a single site and was most recently updated in August 4th 20202."

Answered by AI

Is it feasible to join this trial?

"This clinical trial is enrolling 50 individuals with coronavirus disease between the ages of 18 and 80. To be considered for participation, patients must meet certain criteria: aptitude in using a phone; understanding protocol after reading consent form; fulfilling Centers for Disease Control and Prevention guidelines regarding discontinuation from home isolation; being clinically healthy enough to complete the study based on medical history assessments like cardiovascular conditions."

Answered by AI

Is there an upper cutoff age for participants in this investigation?

"The requirements for this trial stipulate that applicants should be between 18 and 80 years old. There are currently 151 studies available to those younger than 18, while 1066 can benefit from trials targeting patients older than 65."

Answered by AI

What is the maximum capacity of participants in this research project?

"Affirmative. According to the information on clinicaltrials.gov, this research project is currently recruiting participants having first been posted on June 15th 2022. The study needs 50 individuals from 1 medical facility and has most recently been updated on August 4th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

tDCS for Post COVID-19 Fatigue

Thorsten Rudroff 2022. "tDCS for Post COVID-19 Fatigue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04876417.